Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2026-03-02 @ 4:12 AM
Study NCT ID:
NCT06531018
Status:
RECRUITING
Last Update Posted:
2025-02-18
First Post:
2024-07-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.
Sponsor:
Renata PLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-07
Start Date Type:
ACTUAL
Primary Completion Date:
2025-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-07-06
First Submit QC Date:
None
Study First Post Date:
2024-07-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-15
Last Update Post Date:
2025-02-18
Last Update Post Date Type:
ACTUAL